- Home
- MD vs TVTX Comparison
MD vs TVTX Comparison
Compare MD & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MD
- TVTX
- Stock Information
- Founded
- MD 1979
- TVTX 2008
- Country
- MD United States
- TVTX United States
- Employees
- MD N/A
- TVTX N/A
- Industry
- MD Hospital/Nursing Management
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MD Health Care
- TVTX Health Care
- Exchange
- MD Nasdaq
- TVTX Nasdaq
- Market Cap
- MD 1.2B
- TVTX 1.4B
- IPO Year
- MD 1995
- TVTX N/A
- Fundamental
- Price
- MD $13.22
- TVTX $14.31
- Analyst Decision
- MD Buy
- TVTX Strong Buy
- Analyst Count
- MD 6
- TVTX 15
- Target Price
- MD $16.67
- TVTX $33.57
- AVG Volume (30 Days)
- MD 944.8K
- TVTX 1.6M
- Earning Date
- MD 08-05-2025
- TVTX 07-31-2025
- Dividend Yield
- MD N/A
- TVTX N/A
- EPS Growth
- MD N/A
- TVTX N/A
- EPS
- MD N/A
- TVTX N/A
- Revenue
- MD $1,976,177,000.00
- TVTX $273,533,000.00
- Revenue This Year
- MD N/A
- TVTX $73.84
- Revenue Next Year
- MD $3.26
- TVTX $46.72
- P/E Ratio
- MD N/A
- TVTX N/A
- Revenue Growth
- MD N/A
- TVTX 75.65
- 52 Week Low
- MD $6.62
- TVTX $6.80
- 52 Week High
- MD $17.67
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- MD 38.13
- TVTX 38.47
- Support Level
- MD $13.78
- TVTX $13.88
- Resistance Level
- MD $14.44
- TVTX $15.04
- Average True Range (ATR)
- MD 0.41
- TVTX 0.69
- MACD
- MD -0.11
- TVTX 0.02
- Stochastic Oscillator
- MD 7.74
- TVTX 24.43
About MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.